What are the benefits of lion's mane, chaga, and ashwagandha, and are there any drug interactions with sertraline, trazodone, aripiprazole (Abilify), and hydroxyzine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Benefits and Drug Interactions of Lion's Mane, Chaga, and Ashwagandha with Your Psychiatric Medications

These supplements can be used cautiously with your medication regimen (sertraline, trazodone, Abilify, hydroxyzine), but ashwagandha requires the most vigilance due to potential endocrine effects and liver toxicity, while lion's mane and chaga appear relatively safer with no documented major drug interactions with your specific medications.

Benefits of Each Supplement

Lion's Mane (Hericium erinaceus)

  • Cognitive and mood effects: Shows promise for improving cognitive function and reducing subjective stress in healthy adults, with one study demonstrating improved performance speed on cognitive tasks after a single 1.8g dose 1
  • Antidepressant potential: Contains bioactive compounds that promote nerve growth factor expression and may offer antidepressant-like effects through neurotrophic mechanisms 2
  • General health: Demonstrates antioxidant, anti-inflammatory, and neuroprotective properties 3

Chaga (Inonotus obliquus)

  • Antioxidant properties: High in bioactive compounds with antioxidant and anti-inflammatory effects
  • Immune support: Contains β-glucans that may provide immunomodulatory benefits 3
  • Limited specific research: Less clinical evidence compared to lion's mane, but generally recognized for antioxidant capacity

Ashwagandha (Withania somnifera)

  • Stress and mood: Robust adaptogenic properties with ability to reduce cortisol levels and promote brain-derived neurotrophic factor 4
  • Antidepressant mechanisms: Modulates monoaminergic pathways (serotonin, dopamine, norepinephrine), reduces inflammation, and supports neurogenesis 4
  • Multiple pathways: Targets stress response, neurotrophic support, and inflammatory regulation relevant to depression 4

Drug Interaction Analysis

Interactions with Sertraline (SSRI)

No documented interactions with lion's mane, chaga, or ashwagandha in the provided evidence. The FDA label for Abilify specifically states that no dosage adjustment is necessary for sertraline when coadministered with aripiprazole 5, and the combination of aripiprazole with sertraline has been studied and found safe 6.

Interactions with Trazodone

No specific interactions documented in the evidence provided. However, general caution is warranted with any supplement affecting serotonin when combined with serotonergic medications.

Interactions with Abilify (Aripiprazole)

No direct interactions between these supplements and aripiprazole are documented. The FDA label indicates that aripiprazole is metabolized primarily through CYP3A4 and CYP2D6 pathways 5. None of these three supplements are known strong inhibitors or inducers of these pathways based on the evidence provided.

Interactions with Hydroxyzine

No documented interactions with these supplements in the evidence provided.

Critical Safety Considerations

Ashwagandha-Specific Warnings

  • Liver toxicity: Recent evidence highlights concerns about hepatotoxicity, particularly with prolonged or excessive use 7
  • Endocrine disruption: Can cause thyrotoxicosis and adrenal suppression; monitor thyroid function if using long-term 7
  • Gastrointestinal effects: May cause GI side effects 7
  • CYP450 metabolism: Metabolized via cytochrome P450 enzymes, which can form reactive intermediates leading to oxidative stress 7

General Mushroom Supplement Considerations

  • Potential interactions: Medicinal mushrooms can affect drug pharmacodynamics and pharmacokinetics, especially for drugs with narrow therapeutic indices 8
  • Limited human data: Most interaction data comes from preclinical studies; clinical evidence remains limited 8

Perioperative Context (Not Directly Applicable But Informative)

The SPAQI consensus statement 9 does not specifically address lion's mane, chaga, or ashwagandha, suggesting these supplements lack sufficient evidence for major perioperative concerns compared to supplements with known antiplatelet or sedative effects.

Practical Recommendations

Start with lion's mane if seeking cognitive and mood benefits, as it has the most favorable safety profile and emerging clinical evidence for stress reduction 1. Use 1.8g daily based on the studied dose.

Chaga can be added for general antioxidant support with minimal concern for interactions, though clinical evidence is more limited.

Approach ashwagandha with caution:

  • Monitor for signs of liver dysfunction (fatigue, jaundice, abdominal pain)
  • Check thyroid function before starting and periodically during use
  • Avoid if you have pre-existing liver or thyroid conditions
  • Use standardized extracts at recommended doses only
  • Consider it only if the potential benefits clearly outweigh risks given your psychiatric medication regimen

Monitor for additive sedation when combining any of these supplements with your current medications, particularly trazodone and hydroxyzine, which have sedative properties.

Inform your prescribing physician before starting these supplements, especially given your complex psychiatric medication regimen. While no major documented interactions exist, individual responses vary and clinical monitoring is prudent.

References

Research

Therapeutic Potential of Hericium erinaceus for Depressive Disorder.

International journal of molecular sciences, 2019

Related Questions

Can Lion's mane (Hericium erinaceus) supplementation cause irritability in adults, including those using it for cognitive support or mild cognitive impairment?
Are reishi and lions mane mushrooms safe for medicinal use?
For a patient taking GABA or ashwagandha, how do their mechanisms of action differ and should they be classified as vitamins, antibiotics, or medications in a public‑health audit?
What are the anesthetic implications of ashwagandha supplementation and how should it be managed prior to surgery?
How does Ashwagandha affect blood pressure, and what dosing and monitoring recommendations apply for patients on antihypertensive medications or with low or normal blood pressure?
For a 42-year-old healthy male on lisinopril, bupropion (Wellbutrin), and sildenafil with serum creatinine 1.32 mg/dL, what dosing adjustments or monitoring are recommended?
What does the term 'myxoid' mean in pathology?
What type of dressings are recommended for deep tissue injuries (DTIs)?
What is the appropriate Vyvanse (lisdexamfetamine) dose when switching a patient from Adderall (mixed amphetamine salts) 40 mg daily?
What is the recommended outpatient treatment protocol for complicated rhinosinusitis in an adult?
I am a 30‑year‑old Black male, 6'5" and 318 lb, with normal renal and hepatic function, CK around 527 U/L, positive ANA (titer 1:160) and markedly elevated anti‑RNP antibodies, proximal muscle weakness, thigh hyperpigmentation, G6PD deficiency, and pending EMG and muscle biopsy—what is the most likely diagnosis, what is the prognosis and is this condition life‑threatening, and are turmeric or oregano oil safe for me?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.